Back to Search Start Over

COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease

Authors :
Beretta, S
Stabile, A
Balducci, C
Difrancesco, J
Patruno, A
Rona, R
Bombino, M
Capraro, C
Andreetta, F
Cavalcante, P
Moda, F
Citerio, G
Foti, G
Bogliun, G
Ferrarese, C
Beretta, Simone
Stabile, Andrea
Balducci, Claudia
DiFrancesco, Jacopo C.
Patruno, Adriana
Rona, Roberto
Bombino, Michela
Capraro, Cristina
Andreetta, Francesca
Cavalcante, Paola
Moda, Fabio
Citerio, Giuseppe
Foti, Giuseppe
Bogliun, Graziella
Ferrarese, Carlo
Beretta, S
Stabile, A
Balducci, C
Difrancesco, J
Patruno, A
Rona, R
Bombino, M
Capraro, C
Andreetta, F
Cavalcante, P
Moda, F
Citerio, G
Foti, G
Bogliun, G
Ferrarese, C
Beretta, Simone
Stabile, Andrea
Balducci, Claudia
DiFrancesco, Jacopo C.
Patruno, Adriana
Rona, Roberto
Bombino, Michela
Capraro, Cristina
Andreetta, Francesca
Cavalcante, Paola
Moda, Fabio
Citerio, Giuseppe
Foti, Giuseppe
Bogliun, Graziella
Ferrarese, Carlo
Publication Year :
2021

Abstract

We report a subtype of immune-mediated encephalitis associated with COVID-19, which closely mimics acute-onset sporadic Creutzfeldt-Jakob disease. A 64-year-old man presented with confusion, aphasia, myoclonus, and a silent interstitial pneumonia. He tested positive for SARS-CoV-2. Cognition and myoclonus rapidly deteriorated, EEG evolved to generalized periodic discharges and brain MRI showed multiple cortical DWI hyperintensities. CSF analysis was normal, except for a positive 14-3-3 protein. RT-QuIC analysis was negative. High levels of pro-inflammatory cytokines were present in the CSF and serum. Treatment with steroids and intravenous immunoglobulins produced EEG and clinical improvement, with a good neurological outcome at a 6-month follow-up.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1308942158
Document Type :
Electronic Resource